Upregulation of long non­coding RNA LINC00460 in EGFR­mutant lung cancer indicates a poor prognosis in patients treated with osimertinib.

Nakano, Yuta; Isobe, Kazutoshi; Yoshizawa, Takahiro; Urabe, Naohisa; Homma, Sakae; Kishi, Kazuma

Upregulation of long noncoding RNA LINC00460 in EGFRmutant lung cancer indicates a poor prognosis in patients treated with osimertinib.

Nakano, Yuta; Isobe, Kazutoshi; Yoshizawa, Takahiro; Urabe, Naohisa; Homma, Sakae; Kishi, Kazuma.

Afiliação

Nakano Y; Department of Respiratory Medicine, Toho University School of Medicine, Tokyo 143-8541, Japan.
Isobe K; Pharmaceutical & ADMET Research Development, Daiichi Sankyo RD Novare Co., Ltd, Tokyo 134-8630, Japan.
Yoshizawa T; Department of Respiratory Medicine, Toho University School of Medicine, Tokyo 143-8541, Japan.
Urabe N; Department of Respiratory Medicine, Toho University School of Medicine, Tokyo 143-8541, Japan.
Homma S; Department of Respiratory Medicine, Toho University School of Medicine, Tokyo 143-8541, Japan.
Kishi K; Department of Respiratory Medicine, Toho University School of Medicine, Tokyo 143-8541, Japan.

Oncol Lett ; 26(3): 380, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37559586

Palavras-chave

LINC00460; NSCLC; lncRNA; osimertinib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google